Talaris Therapeutics

Talaris Therapeutics Stock News
View all



Frequently Asked Questions (FAQ)
How to buy TALS stock on Public
- 1
Sign up for a brokerage account on Public
It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.
- 2
Add funds to your Public account
There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.
- 3
Choose how much you'd like to invest in TALS stock
Navigate to the Explore page. Then, type TALS into the search bar. When you see TALS stock appear in the results, tap it to open up the purchase screen.
- 4
Manage your investments in one place
You can find your newly purchased TALS stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.
Talaris Therapeutics Stock Earnings
The value each TALS share was expected to gain vs. the value that each TALS share actually gained.
Talaris Therapeutics (TALS) reported Q2 2023 earnings per share (EPS) of -$3.50, missing estimates of -$1.50 by 133.33%. In the same quarter last year, Talaris Therapeutics's earnings per share (EPS) was -$4.40. Talaris Therapeutics is expected to release next earnings on 08/14/2023, with an earnings per share (EPS) estimate of $0.